54 – High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy: long-term results

AUTORI: Carella AM., Bellei M., Brice P., Gisselbrecht C., Visani G., Federico M. et al.

No abstract available

Abstract Purpose: It remains uncertain whether ethnicity affects the benefit derived from novel breast cancer (BC)

NO ABSTRACT AVAILABLE

Abstract Background: Young, healthy women carrying a pathogenic or likely pathogenic variant (P/LPV) in genes configuring

Abstract Endometrial cancer (EC) incidence and mortality rates have been increasing, particularly among young females.

Abstract Background: The management of severe complications arising from newly diagnosed or existing cancer, as well

Abstract Purpose: Hodgkin lymphoma (HL) is classified as the first malignancy to be cured by a